N-乙酰基-S-（3,4-二羟基丁基）-L-半胱氨酸（非对映异构体的混合物）

N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (Mixture of Diastereomers)

Fmoc-L-异亮酰氯

Fmoc-L-Isoleucyl Chloride

2-氟-L-苯丙氨酸, 99.9%

2-Fluoro-L-phenylalanine

N-[（（5-氨基-1-苯基-1H-吡唑-4-基）-羰基]乙基肼基甲酸乙酯

Ethyl N-[(5-amino-1-phenyl-1H-pyrazol-4-yl)-carbonyl]ethanehydrazonoate

(8α,9R)-奎宁-6',9-二醇, ≥98%,99.9%d.e.

(8α,9R)-Cinchonan-6',9-diol

CY5-YNE, >98%

CY5-YNE

AMG-517, 99.9%

AMG-517

BPR1J-097, 99%

BPR1J-097

CX-6258盐酸盐, 99.9%

CX-6258 HCl

Duvelisib R enantiomer, ≥99%

Duvelisib R enantiomer

JQ-1 carboxylic acid , ≥99.9%

JQ-1 carboxylic acid 

Desmethyl Erlotinib, 99%

Desmethyl Erlotinib

Sabutoclax, 99.9%

BI-97C1

UNC 0631 , ≥99%

UNC 0631 

Selpercatinib(LOXO-292), 99%

Selpercatinib(LOXO-292)

氨磷汀三水合物, ≥98%

Amifostine trihydrate

泰伦那班(1R,2R)立体异构体, 99%

Taranabant ((1R,2R)stereoisomer) (MK0364 (1R,2R)stereoisomer)

2,4,5,6-四(9-咔唑基)-间苯二腈, 98%, unsublimated

2,4,5,6-tetrakis(carbazol-9-yl)-1,3-dicyanobenzene

(8S,9S,10R,14S)-13-乙基-11-亚甲基-1,2,3,6,7,8,9,10,11,12,13,14,15,16-十四氢-17H-环戊[a]菲-17-酮, 98%

(8S,9S,10R,14S)-13-Ethyl-11-methylene-2,3,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(6H)-one

1-(cyclopropylmethyl)-3-hydroxyquinazoline-2,4(1H,3H)-dione, ≥99%

FEN1-IN-4